Your search returned 6 results.

Results
	1.	Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts. [electronic resource] by Lopes de Menezes, Daniel E Mayer, Lawrence D Producer: 20020308 In: Cancer chemotherapy and pharmacology vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice. [electronic resource] by Lopes de Menezes, Daniel E Hu, Yanping Mayer, Lawrence D Producer: 20031106 In: Journal of experimental therapeutics & oncology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models. [electronic resource] by Lee, Sang Hoon Lopes de Menezes, Daniel Vora, Jayesh Harris, Alex Ye, Helen Nordahl, Lara Garrett, Evelyn Samara, Emil Aukerman, Sharon Lea Gelb, Arnold B Heise, Carla Producer: 20050823 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia. [electronic resource] by Lopes de Menezes, Daniel E Peng, Jing Garrett, Evelyn N Louie, Sharianne G Lee, Sang H Wiesmann, Marion Tang, Yan Shephard, Lee Goldbeck, Cheryl Oei, Yoko Ye, Helen Aukerman, Sharon L Heise, Carla Producer: 20051107 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. [electronic resource] by Tse, Archie N Rendahl, Katherine G Sheikh, Tahir Cheema, Haider Aardalen, Kim Embry, Millicent Ma, Sylvia Moler, Edward J Ni, Zhi Jie Lopes de Menezes, Daniel E Hibner, Barbara Gesner, Thomas G Schwartz, Gary K Producer: 20070424 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma. [electronic resource] by Lopes de Menezes, Daniel E Denis-Mize, Kimberly Tang, Yan Ye, Helen Kunich, John C Garrett, Evelyn N Peng, Jing Cousens, Lawrence S Gelb, Arnold B Heise, Carla Wilson, Susan E Jallal, Bahija Aukerman, Sharon L Producer: 20070302 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)